TXMD - Total Utang marang Modal TherapeuticsMD

TherapeuticsMD, Inc. (TXMD) develops specialized pharmaceuticals for the female body. Historical price action on the GURU.Markets platform illustrates the impact of implementing cloud IT solutions and AI in logistics, with the indicator standing at 0.19. The company relies on physician loyalty and a transparent licensing policy. A high barrier to entry in the niche is ensured by strict FDA control and exclusive patents on hormone delivery methods.

TXMD: Total Utang marang Modal TherapeuticsMD Corp 04.07.2022 - 31.10.2026

Rincian analitis perusahaan TherapeuticsMD, Inc.

- rega lan prakiraan konsensus rega:

Bagan rega TherapeuticsMD Inc|TXMD - Bagan tingkat prakiraan

- statistik kapitalisasi pasar:

Kapitalisasi pasar TherapeuticsMD|TXMD - Nilai Dipunlarasaken Utang lan Kas

- indikator kapitalisasi buku:

Nilai Buku saben Saham TherapeuticsMD|TXMD - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku therapeuticsmd.com|TXMD - Nilai Agregat Aset

- indikator total utang lan likuiditas perusahaan:

Utang marang Ekuitas TherapeuticsMD, Inc.|TXMD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal TherapeuticsMD Inc|TXMD - Gunggung utang perusahaan|Utang marang nilai buku TherapeuticsMD|TXMD - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan TherapeuticsMD|Likuiditas cepet therapeuticsmd.com

- informasi bathi lan kelipatan valuasi:

TXMD - Penghasilan resik perusahaan

Analisis dhasar perusahaan:TherapeuticsMD, Inc.

A conservative investor assesses the financial stability of TherapeuticsMD, Inc. (TXMD) through the balance of debt and equity. This ratio aggregates all company liabilities and compares them to net equity; by analyzing the business's debt-to-equity ratio, one can confirm that predictable sales of women's health medications minimize the risks of excessive leverage, creating a robust investment profile.

Analisis pesaing TherapeuticsMD, Inc.

Utang marang Ekuitas Organon|Dare Bioscience - Utang Agregat marang Ekuitas|Total Utang marang Modal PTN